Clinical Trial Update: Chidamide for Maintenance Treatment of HBV-infected Diffuse DLBCL in Patients Initially Treated With R-CHOP [Phase 3]

View source ↗

Summary

An ongoing Phase 3 trial evaluating chidamide as maintenance therapy for HBV-infected diffuse large B-cell lymphoma after R-CHOP is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Chidamide (chidamide)

Snippet

Sponsor: Ou Bai, MD/PHD | Conditions: Diffuse Large B-Cell Lymphoma (DLBCL) | Phase 3 | Status: RECRUITING